From the Helm: CSL’s David Lamont on the biotech giant’s bright future

Jessica Amir
February 20, 2020

In the latest instalment of Bell Direct’s From the Helm series, Jess has a chat with CSL’s CFO David Lamont.

David gives the inside scoop on CSL, the market leader in the blood plasma and vaccine market. Additionally, he explains CSL’s own products, programmes and partnerships, and the steps taken by the medical giant to tackle coronavirus.

Plus, he sheds some light on the unique situation the broader pharmaceuticals industry finds itself in when it comes to new competition, as well as CSL’s future proofing strategy.

Morning Bell 27 April

Jessica Amir
April 27, 2021

Morning Bell 26 April

Jessica Amir
April 26, 2021

Weekly Wrap 23 April

Jessica Amir
April 23, 2021

Morning Bell 23 April

Jessica Amir
April 23, 2021

Morning Bell 22 April

Jessica Amir
April 22, 2021

Morning Bell 21 April

Sophia Mavridis
April 21, 2021

Morning Bell 20 April

Sophia Mavridis
April 20, 2021

Morning Bell 19 April

Paulina Peters
April 19, 2021

Weekly Wrap 16 April

Jessica Amir
April 16, 2021

Morning Bell 16 April

Jessica Amir
April 16, 2021